NCT00019786View on ClinicalTrials.gov

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

January 31, 2006

Conditions

Colorectal CancerIslet Cell TumorLiver CancerMetastatic CancerNeuroendocrine Carcinoma

Interventions

DRUG

isolated perfusion

DRUG

melphalan

PROCEDURE

conventional surgery

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00019786 - Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | Biotech Hunter | Biotech Hunter